Drug Combo Tolerated in Younger Children With Cystic Fibrosis

Lumacaftor/ivacaftor safe in children ages 2 to 5 with cystic fibrosis homozygous for F508del - CFTR
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news